H
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
Price:
3.68
CNY
-0.81%
Market Closed
Market Cap:
¥7.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
|
CN |
|
Gemilang International Ltd
HKEX:6163
|
MY |
|
Seadrill Ltd
OSE:SDRL
|
BM |
|
Wuxi Lihu Corporation Limited
SZSE:300694
|
CN |
|
Sok Marketler Ticaret AS
IST:SOKM.E
|
TR |
|
Gansu Yatai Industrial Development Co Ltd
SZSE:000691
|
CN |
|
MotorCycle Holdings Ltd
ASX:MTO
|
AU |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
Petroreconcavo SA
BOVESPA:RECV3
|
BR |
|
Bure Equity AB
STO:BURE
|
SE |
|
Bots Inc
OTC:BTZI
|
PR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hunan Er-Kang Pharmaceutical Co Ltd's stock price target?
Not Available
Hunan Er-Kang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hunan Er-Kang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%
10%
For the last 13 years the compound annual growth rate for Hunan Er-Kang Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 8 years is 10%.
